Cancer immunotherapy: avoiding the road to perdition
The hypothesis that human cancers express antigens that can be specifically targeted by cell mediated immunity has become a scientifically justifiable rationale for the design and clinical testing of novel tumor-associated antigens (TAA). Although a number of TAA have been recognized and it has been...
Guardado en:
| Publicado en: | J Transl Med |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2004
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC509287/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15283862/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1479-5876-2-26 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|